Remove Bioethics Remove Licensing Remove Research
article thumbnail

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application

The Pharma Data

Authors of “ An ethical exploration of barriers to research on controlled drugs ” in the American Journal of Bioethics have been quoted stating, “the classification of drugs as Schedule I amounts to an unsurmountable barrier to research.” For further information please visit www.abetterlifephama.com.

article thumbnail

Deliberate Dysentery

Codon

We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. When a vaccine fails, that can have downstream effects on how other researchers in the field approach their own vaccine development, and how funding gets moved around. That's not coincidental.

Vaccine 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nucleic Acids Research (2010). FEMS Yeast Research (2015).

DNA 91
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nucleic Acids Research (2010).

DNA 52